Tessera Therapeutics

Cambridge, MA · Founded 2018 · Privately Held (backing)

Developer of a gene writing technology designed to make permanent small and large alterations to the human genome. Tessera Therapeutics is based in Cambridge, MA and was founded in 2018. Its last reported valuation was $650 million in Dec 2024. It has raised $630 million.

Last reported valuation

$650.0M

Oct 2026

Priced at

—

Total raised

$630.0M

Last round

—

How much has Tessera Therapeutics raised?

$630.0Macross 0 recorded rounds

Free account

More of Tessera Therapeutics with a free account

·The complete investor list: 29 names
·Watch Tessera Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Tessera Therapeutics investors

29 investors are on record for Tessera Therapeutics, including SoftBank Investment Advisers, University of California, Gates Foundation and EDBI. By type, the record holds 11 venture capital firms and 1 growth equity firm.

For fundraisers

Raising for a company like Tessera Therapeutics?

29 investors have backed Tessera Therapeutics.

See all 29 investors →

Frequently asked about Tessera Therapeutics

How much has Tessera Therapeutics raised?: Tessera Therapeutics has raised $630.0M in total across 0 recorded funding rounds.